-
Product Insights
Ascites Disease – Global Clinical Trials Review, H1, 2021
GlobalData's clinical trial report, “Ascites Disease - Global Clinical Trials Review, H1, 2021" provides an overview of Ascites Clinical trials scenario. This report provides top line data relating to the clinical trials on Ascites . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Ascites Disease – Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Ascites Global Clinical Trials Review, H2, 2020" provides an overview of Ascites Clinical trials scenario. This report provides top line data relating to the clinical trials on Ascites. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Global Clinical Trials Review, H1, 2017" provides an overview of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) clinical trials scenario. This report provides top line data relating to the clinical trials on Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase,...
-
Product Insights
Ascites Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Ascites Global Clinical Trials Review, H1, 2017" provides an overview of Ascites clinical trials scenario. This report provides top line data relating to the clinical trials on Ascites. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Granulomatosis with Polyangiitis (Wegener Polyangiitis) Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Granulomatosis with Polyangiitis (Wegener Polyangiitis) Global Clinical Trials Review, H2, 2016" provides an overview of Granulomatosis with Polyangiitis (Wegener Polyangiitis) clinical trials scenario. This report provides top line data relating to the clinical trials on Granulomatosis with Polyangiitis (Wegener Polyangiitis). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end...
-
Product Insights
Microscopic Polyangiitis (MPA) Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Microscopic Polyangiitis (MPA) Global Clinical Trials Review, H2, 2016" provides an overview of Microscopic Polyangiitis (MPA) clinical trials scenario. This report provides top line data relating to the clinical trials on Microscopic Polyangiitis (MPA). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Ascites Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Ascites Global Clinical Trials Review, H1, 2016" provides an overview of Ascites clinical trials scenario. This report provides top line data relating to the clinical trials on Ascites. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Exocrine Pancreatic Insufficiency Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Exocrine Pancreatic Insufficiency Global Clinical Trials Review, H2, 2016" provides an overview of Exocrine Pancreatic Insufficiency clinical trials scenario. This report provides top line data relating to the clinical trials on Exocrine Pancreatic Insufficiency. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Ascites Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Ascites Global Clinical Trials Review, H2, 2016" provides an overview of Ascites clinical trials scenario. This report provides top line data relating to the clinical trials on Ascites. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Sector Analysis
PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis – Global Drug Forecast and Market Analysis to 2025
Systemic lupus erythematosus (SLE) is a systemic inflammatory autoimmune disease that can affect any organ or tissue and is the prototypic autoimmune disease. As a multisystem disorder, SLE is heterogeneous in nature—no two cases of lupus are alike—and can affect multiple major organ systems in the body, one of its most severe manifestations includes renal (kidney) involvement, known as lupus nephritis (LN). The etiology of SLE and LN remains incompletely understood, but genetic and environmental factors have been shown to...
-
Product Insights
Granulomatosis with Polyangiitis (Wegener Polyangiitis) Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Granulomatosis with Polyangiitis (Wegener Polyangiitis) Global Clinical Trials Review, H2, 2017" provides an overview of Granulomatosis with Polyangiitis (Wegener Polyangiitis) clinical trials scenario. This report provides top line data relating to the clinical trials on Granulomatosis with Polyangiitis (Wegener Polyangiitis). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end...
-
Sector Analysis
North America Cardiac Rhythm Management Devices Market Outlook to 2025
“What is covered in the report about the “North America Cardiac Rhythm Management Devices Market”? GlobalData’s “North America Cardiac Rhythm Management Devices Market Outlook to 2025” report is a comprehensive databook report, covering key market data on the North America Cardiac Rhythm Management Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD), Implantable Loop Recorders (ILR) and Pacemakers. The North America Cardiac Rhythm...
-
Product Insights
Microscopic Polyangiitis (MPA) Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Microscopic Polyangiitis (MPA) Global Clinical Trials Review, H2, 2017" provides an overview of Microscopic Polyangiitis (MPA) clinical trials scenario. This report provides top line data relating to the clinical trials on Microscopic Polyangiitis (MPA). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Exocrine Pancreatic Insufficiency Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Exocrine Pancreatic Insufficiency Global Clinical Trials Review, H2, 2017" provides an overview of Exocrine Pancreatic Insufficiency clinical trials scenario. This report provides top line data relating to the clinical trials on Exocrine Pancreatic Insufficiency. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Granulomatosis with Polyangiitis (Wegener’s Granulomatosis) Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Granulomatosis with Polyangiitis (Wegener's Granulomatosis) Global Clinical Trials Review, H2, 2018" provides an overview of Granulomatosis with Polyangiitis (Wegener's Granulomatosis) clinical trials scenario. This report provides top line data relating to the clinical trials on Granulomatosis with Polyangiitis (Wegener's Granulomatosis). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end...
-
Sector Analysis
Competitor Landscape: Lupus
Sociable Pharma’s ‘Treatment Landscape’ contains evaluations of ongoing development activities within the Lupus market, analysis of current & potential future product positioning, and forecast approval dates (by quarter) for candidates in Phase II development, or higher
-
Product Insights
Ascites Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Ascites Global Clinical Trials Review, H2, 2018" provides an overview of Ascites clinical trials scenario. This report provides top line data relating to the clinical trials on Ascites. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.